1.   Eli Lilly and Co. does not want to pay the higher rebates for its insulin products.

2.   His favorites include Belmont-based Inhale Therapeutics, which is developing an inhaled insulin product.

3.   It is working with Pfizer Inc. to develop the first inhaled insulin product that both companies hope to have approved by the FDA next year.

4.   Pfizer and Inhale are developing inhaled insulin products that combine the drug in a powder or wet form with a pump or breathing device known as an inhaler.

5.   Several other companies, like Eli Lilly, are working on inhaled insulin products.

6.   The injunction prevented Eli Lilly from selling its insulin product, called Humulin, in the United States, Novo Nordisk said.